JPRN-UMIN000009172招募中2 期
Phase II study of neoadjuvant S-1 concurrent radiotherapy for borderline resectable pancreatic cancer - JASPAC05
JASPAC0 个研究点目标入组 50 人开始时间: 2012年10月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)no prior fluoropyrimidine anticancer therapy 2)prior abdominal radiotherapy 3)diarrhea 4)iodine contrast allergy 5)pulmonary fibrosis or interstitial pneumonitis 6)ascites or pleural effusion 7)active infection 8)poor controlled diabetes 9)active other malignancy 10)active digestive ulcer 11)serious complications 12)continuous steroid administration 13)severe mental disorder 14)pregnancy
研究者
相似试验
已完成
2 期
A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancerJPRN-UMIN000000486Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital60
已完成
2 期
A Phase II Study of Oral S-1 with Concurrent Radiotherapy for Locally Advanced Pancreatic Cancerlocally advanced and unresectable pancreatic cancerJPRN-UMIN000004794HIROYUKI SHINCHI50
招募中
不适用
A clinical trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancerJPRN-UMIN000005420Department of Gastroenterology, BELL LAND General Hospital10
已完成
2 期
Phase II study of chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal cancer (definitive chemoradiotherapy)JPRN-UMIN000014683Osaka International Cancer Institute38
已完成
2 期
Phase II study of chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal cancer (endoscopic resection followed by chemoradiotherapy)JPRN-UMIN000014684Osaka International Cancer Institute38